Xeris Pharmaceuticals | XERS - EPS Earnings Per Share


Xeris Pharmaceuticals reported $0.01 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.01 0.01 -0.06 May/07




Eps Change Date
Celltrion KRW 1.58K 709.78 Mar/2026
Cspc Pharmaceutical CNY 0.08 0.08 Mar/2026
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Divis Laboratories Ltd INR 28.29 6.31 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Kangmei Pharma CNY 0 0 Mar/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.01 0.15 Mar/2026
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pharma Mar EUR 0.09 3.25 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
Sartorius EUR 1.2 0.06 Mar/2026
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Tilray USD -0.41 0.4 Dec/2025
Zealand Pharma A/S -8.34 2.6 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.24 0.51 Mar/2026